Agenus (AGEN) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free AGEN Stock Alerts $8.30 +0.88 (+11.86%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAgenus Inc. (NASDAQ:AGEN) Sees Significant Decrease in Short Interestamericanbankingnews.com - April 26 at 1:32 AMAgenus Inc. (NASDAQ:AGEN) Short Interest Updatemarketbeat.com - April 25 at 7:06 PMBotensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meetingfinance.yahoo.com - April 24 at 10:20 AMTop 2 Health Care Stocks Which Could Rescue Your Portfolio This Month - Agenus (NASDAQ:AGEN), MultiPlan (NYSE:MPLN)benzinga.com - April 23 at 8:36 AMAgenus to Provide First Quarter 2024 Financial Report and Corporate Updatebusinesswire.com - April 23 at 7:30 AMStockNews.com Begins Coverage on Agenus (NASDAQ:AGEN)americanbankingnews.com - April 17 at 2:14 AMCommit To Purchase Agenus At $1, Earn 2607.1% Annualized Using Optionsnasdaq.com - April 13 at 10:12 PMSmall-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loommarkets.businessinsider.com - April 12 at 5:46 PMAgenus Updates Phase 1 Data Of BOT/BAL Therapy In MSS Metastatic Colorectal Cancernasdaq.com - April 12 at 12:45 PMAgenus Stock Falls After Reporting Updated Phase 1 Data On Colorectal Cancer Therapymarkets.businessinsider.com - April 12 at 12:45 PMAgenus reports updated Phase 1 data on colorectal cancer therapymsn.com - April 12 at 12:45 PMAgenus (NASDAQ:AGEN) Reaches New 12-Month Low at $8.10marketbeat.com - April 12 at 10:53 AMAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancerfinance.yahoo.com - April 12 at 7:45 AMAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancerbusinesswire.com - April 12 at 7:30 AMmarketbeat.com - April 12 at 6:04 AMAgenus (NASDAQ:AGEN) Shares Scheduled to Reverse Split on Friday, April 12thmarketbeat.com - April 8 at 7:31 PMMiNK Therapeutics' MiNK-215 Data Show Potential Treatment for Liver Metastasesmarketwatch.com - April 8 at 2:35 PMDown 75%. Is Agenus Stock a Buy on the Dip?fool.com - April 8 at 3:34 AMAgenus announces reverse stock split to meet Nasdaq requirementsinvesting.com - April 7 at 9:48 AMAgenus Announces Reverse Stock Split of Common Stockbusinesswire.com - April 5 at 4:30 PMAssenagon Asset Management S.A. Acquires 2,232,064 Shares of Agenus Inc. (NASDAQ:AGEN)marketbeat.com - April 5 at 4:29 AM2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?fool.com - April 3 at 4:19 AM3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Millioninvestorplace.com - March 24 at 4:05 PMAGEN Aug 2024 2.000 putca.finance.yahoo.com - March 20 at 4:39 AMAgenus (NASDAQ:AGEN) Rating Reiterated by HC Wainwrightmarketbeat.com - March 18 at 3:10 PMAgenus (NASDAQ:AGEN) Price Target Cut to $5.00 by Analysts at B. Rileymarketbeat.com - March 18 at 3:10 PMUS$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Resultsfinance.yahoo.com - March 17 at 10:17 AMBuy Rating Affirmed for Agenus Amidst Promising Cancer Immunotherapy Developments and Strategic Financial Movesmarkets.businessinsider.com - March 16 at 1:18 AMEarnings Preview For Agenusbenzinga.com - March 15 at 8:17 PMAgenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 3:17 PMAnalysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramaticallyfinance.yahoo.com - March 15 at 10:16 AMAGEN Mar 2024 2.000 putca.finance.yahoo.com - March 15 at 12:15 AMAgenus Poised for Growth: Anticipated BLA Filing and Promising Clinical Data Underpin Buy Ratingmarkets.businessinsider.com - March 14 at 7:15 PMDogecoin spikes after Musk hints at Tesla payment optionfinance.yahoo.com - March 14 at 2:15 PMAgenus (AGEN) Q4 2023 Earnings Call Transcriptfool.com - March 14 at 2:15 PMAgenus: Q4 Earnings Snapshotsfgate.com - March 14 at 9:14 AMAgenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipelinegurufocus.com - March 14 at 8:03 AMAgenus Reports Fourth Quarter and Full Year 2023 Resultsbusinesswire.com - March 14 at 7:30 AMHere's what to expect from Agenus's earnings reportmarkets.businessinsider.com - March 13 at 2:40 PMAgenus (NASDAQ:AGEN) Upgraded at StockNews.commarketbeat.com - March 8 at 11:17 PMAgenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024finance.yahoo.com - March 6 at 7:02 PMAgenus Inc. (NASDAQ:AGEN) Shares Sold by Oracle Investment Management Inc.marketbeat.com - March 1 at 11:48 AMAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Reportfinance.yahoo.com - February 29 at 7:41 AMAgenus Inc. (AGEN) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - February 28 at 12:11 AMAgenus: A Would-Be Rockstar Held Back By Middling Financialsseekingalpha.com - February 27 at 9:09 AMAgenus to Participate in Leerink Partners Global Biopharma Conferencebusinesswire.com - February 26 at 7:30 AMFavourable Signals For Agenus: Numerous Insiders Acquired Stockfinance.yahoo.com - February 19 at 8:32 AMWhy Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Todayfool.com - February 15 at 7:53 PMWhy Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Todayfool.com - February 15 at 6:38 PMGinkgo, Agenus win $31M contract to research adjuvantsmsn.com - February 15 at 2:50 PM Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). AGEN Media Mentions By Week AGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGEN News Sentiment▼0.870.39▲Average Medical News Sentiment AGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGEN Articles This Week▼62▲AGEN Articles Average Week Get Agenus News Delivered to You Automatically Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sangamo Therapeutics News Curis News Omega Therapeutics News Zura Bio News DBV Technologies News BioAtla News Cellectis News Molecular Partners News Cardiol Therapeutics News Outlook Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGEN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agenus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
